SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-016215
Filing Date
2020-06-30
Accepted
2020-06-30 06:03:27
Documents
3
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea123651-6k_alteritytherap.htm 6-K 13885
2 MEETING WITH US FDA PROVIDES DEVELOPMENT PATH FOR ATH434 ea123651ex99-1_alterity.htm EX-99.1 18082
3 GRAPHIC ex99-1_01.jpg GRAPHIC 4258
  Complete submission text file 0001213900-20-016215.txt   39068
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 201000282
SIC: 2834 Pharmaceutical Preparations